Direct-to-consumer Advertising for Urological Pharmaceuticals: A Cross-sectional Analysis of Print Media

Urology

Volumn 75, Issue 5, 2010, Pages 1029-1033

  Folsom, Craig ^a   Fesperman, Susan F ^a   Tojuola, Bayo ^a   Sultan, Shahnaz ^b   Dahm, Philipp ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Hepatology and Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ARTICLE; CLINICAL RESEARCH; DIRECT TO CONSUMER ADVERTISING; DRUG INDUSTRY; DRUG MARKETING; ERECTILE DYSFUNCTION; HEALTH HAZARD; HUMAN; INCONTINENCE; LIFESTYLE; MASS MEDIUM; MEDICAL INFORMATION; PEER REVIEW; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PUBLICATION; SCIENTIFIC LITERATURE; UROLOGICAL CARE;

ADVERTISING AS TOPIC; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; MASS MEDIA; UROLOGY;

EID: 77951667239     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.10.053     Document Type: Article

References (18)

1. Wilkes M.S., Bell R.A., and Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 19 (2000) 110-128
2. Morgan S.G. Direct-to-consumer advertising and expenditures on prescription drugs: a comparison in the United States and Canada. Open Med 1 (2007) 37-45
3. Abel G.A., Lee S.J., and Weeks J.C. Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol 25 (2007) 1267-1271
4. Kravitz R.L., Epstein R.M., Feldman M.D., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 293 (2005) 1995-2002
5. Bell R.A., Kravitz R.L., and Wilkes M.S. Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals. J Fam Pract 49 (2000) 329-335
6. Bell R.A., Kravitz R.L., and Wilkes M.S. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med 14 (1999) 651-657
7. Gellad Z.F., and Lyles K.W. Direct-to-consumer advertising of pharmaceuticals. Am J Med 120 (2007) 475-480
8. Donohue J.M., Cevasco M., and Rosenthal M.B. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 357 (2007) 673-681
9. Rosenthal M.B., Berndt E.R., Donohue J.M., et al. Promotion of prescription drugs to consumers. N Engl J Med 346 (2002) 498-505
10. Gardner D.M., Mintzes B., and Ostry A. Direct-to-consumer prescription drug advertising in Canada: permission by default?. CMAJ 169 (2003) 425-427
11. International Federation of Pharmaceutical Manufacturers & Associations. IFPMA Code of Pharmaceutical Marketing Practices. 2006 Revision (2007) Geneva, Switzerland
12. Bradford W.D., Kleit A.N., Nietert P.J., et al. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood) 25 (2006) 1371-1377
13. Lasser K.E., Allen P.D., Woolhandler S.J., et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287 (2002) 2215-2220
14. In: Baciu A., Straton K., and Burke S.P. (Eds). The Future of Drug Safety: Promoting and Protecting the Health of the Public (2006), Institute of Medicine, Washington, DC
15. Lexchin J., and Mintzes B. Direct-to-consumer advertising of prescription drugs: the evidence says no. J Publ Pol Market 21 (2002) 194-201
16. Kessler D.A., and Pines W.L. The federal regulation of prescription drug advertising and promotion. JAMA 264 (1990) 2409-2415
17. Donohue J.M., Berndt E.R., Rosenthal M., et al. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care 42 (2004) 1176-1185
18. Abel G.A., Neufeld E.J., Sorel M., et al. Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. J Thromb Haemost 6 (2008) 1680-1684